ATS 2024 Final Program

Click on the session title to view the speakers

304

TUESDAY • MAY 21

822 A Rare Case of a Fatal Cerebral Air Embolism After Esophagogastroduodenoscopy 823 A Rare Case of COVID-19 Induced Immune Thrombocytopenic Purpura Resistant to Dexamethasone Therapy: A Case Report and Review of the Literature

509 Pre-COPD and Prism Patients in a Real-life COPD Cohort From the Swedish National Airway Register 510 Characterizing Neighborhoods at High Risk for Chronic Obstructive Pulmonary Disease-related Acute Care Use in Travis County, Texas 511 Trace Elements Are Associated With Development of Emphysema 512 Decline in Lung Function Is Associated With Neighborhood-level Socioeconomic Disadvantage in a Tobacco Exposed Cohort of Individuals With and Without Chronic Obstructive Pulmonary Disease 513 Occupational Lung Disease Mortality Trends in the United States: 1999-2020 514 Cardiopulmonary Failure in Chronic Obstructive Pulmonary Disease (COPD): The Subpopulations and Intermediate Outcome Measures in COPD and Heart Failure Study (SPIROMICS HF) 515 FEV 1 and FVC as Robust Risk Factors for Cardiovascular Disease and Mortality: Insights From a Large Population Study 516 Associations Between Two Week Heart Rate Variability Recordings and Respiratory Health Outcomes in the Atherosclerosis Risk in Communities Study 517 Comparison of Global Lung Initiative (GLI) Global to GLI-2012 Spirometry Reference Equations Across Two Cohorts of Kenyan Adults 518 The Association of the Triglyceride/High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio with Lung Function and Respiratory Outcomes: The NHLBI Pooled Cohort Study 519 Weight Loss in Airway Predominant Chronic Obstructive Pulmonary Disease Is Predicted by the Interaction Between Phytocannabinoids and Endocannabinoids 520 Exposure to Vapours, Gases, Dusts, and Fumes at Work in Relation to Chronic Bronchitis, Emphysema, and Chronic Obstructive Pulmonary Disease: A Systematic Review With Meta-analyses 521 Native American Coal Miners Demonstrate Lower Prevalence of Airflow Obstruction Than Other Coal Miners in New Mexico

CLINICAL POSTER DISCUSSION SESSION

C105 RESPIRATORY REVELATIONS: EPIDEMIOLOGIC STUDIES IN ASTHMA, COPD, AND LUNG FUNCTION 2:15 p.m. - 4:15 p.m.

San Diego Convention Center Room 11A-B (Upper Level)

Poster Viewing

2:15-3:00 3:00-4:15

Discussion

501 Associations of First-trimester Blood Metal Concentrations With Lung Function and Risk of Asthma in Mid-childhood 502 Higher Blood Eosinophil Count Is Associated With Increased Likelihood of Asthma Exacerbation With COVID-19 Infection 503 Innovative, Interactive Platform for Personalized Asthmatic Care 504 Asthma in Healthy Homes: A Public Health Department Approach 505 Exploring the Medication-Related Carbon Footprint of Severe Asthma Pre- and Post-Biologic Therapy in a UK Regional Severe Asthma Service (Northern Ireland) 506 Vitamin D Supplementation Modifies the Estimated Effects of PM2.5 Exposure on Severe Asthma Exacerbations in Children With Low Vitamin D Levels 507 Increased Risk of Acute Exacerbations and Mortality in Short-acting Beta-agonist Overuse Patients: A Systematic Review and Meta-analysis 508 Enhancing Alpha Antitrypsin Deficiency Screening in COPD Patients: A Rural Outpatient Study

ATS 2024 Conference Program • San Diego, CA